Skip to main content

Table 1 Summary of the protective efficacies of the different immunization groups

From: Evaluation of protective efficacy induced by different heterologous prime-boost strategies encoding triosephosphate isomerase against Schistosoma japonicum in mice

Group

No. of mice

Adult worms

Female worms

Eggs in the liver

No. of worms

Reduction (%)

No. of worms

Reduction (%)

No. of eggs

Reduction (%)

Control

11

28 .33 ± 2.55

–

13.67 ± 1.50

–

114,434 ± 17,170

–

DNA vector (i.m.)

12

27.13 ± 6.42

4.26

13.25 ± 3.15

3.05

107,435 ± 25,289

6.12

Ad vector (i.m.)

12

26.50 ± 3.16

6.47

13.00 ± 1.77

4.88

106,826 ± 18,808

6.65

Ad vector (s.c.)

11

26.27 ± 2.72

7.27

12.73 ± 1.35

6.87

109,061 ± 25,571

4.70

DNA (i.m.)

12

19 .22 ± 1.64a

32.16

9.33 ± 1.00a

31.71

72,947 ± 26,998a

36.25

rAdV (i.m.)

12

14.00 ± 4.84a,b

50.59

6.18 ± 1.94a,b

54.77

54,883 ± 26,892a,b

52.04

rAdV (s.c.)

11

18.00 ± 5.24a

36.47

8.63 ± 2.83a

36.89

67,077 ± 21,277a

41.38

rSjTPI (s.c.)

12

20.78 ± 4.52a

26.67

10.22 ± 2.39a

25.20

70,993 ± 28,772a

37.96

DNA (i.m.) + rAdV (i.m.)

11

15.55 ± 4.61a,c

45.13

6.82 ± 2.71a,c

50.11

51,991 ± 11,395a,c

54.57

rAdV (i.m. + s.c.)

12

15.75 ± 6.09a,d

44.41

7.58 ± 2.81a,d

44.51

49,095 ± 14,323a,d

57.10

rAdV (i.m.) + rSjTPI (s.c.)

12

7.91 ± 2.47a,e

72.09

3.73 ± 1.19a,e

72.73

31,891 ± 17,776a,e

72.13

  1. aStatistically significant differences (P < 0.01), compared to the control or vector control group
  2. bStatistically significant differences (P < 0.01), compared to the DNA (i.m.), rAdV (s.c.), or rSjTPI (s.c.) group
  3. cStatistically significant difference (P < 0.01), compared to the DNA (i.m.) group
  4. dStatistically significant difference (P < 0.05), compared to the rAdV (s.c.) group
  5. eStatistically significant differences (P < 0.01), compared to each group